This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Institute of Radiation Medicine, Academy of Military Medical Sciences, Pla.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Zhuangrong Sun: Innovator in Diabetes Treatment
Introduction
Zhuangrong Sun is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment and prevention of diabetes. His innovative work has led to the development of a unique patent that addresses critical health issues.
Latest Patents
Zhuangrong Sun holds a patent for "Cis-1,2-substituted stilbene derivatives and their use in preparation of drugs for treatment and/or prevention of diabetes." This invention relates to cis-1,2-substituted stilbene derivatives, or their pharmaceutically acceptable salts, glucosides, or solvates. The pharmaceutical composition comprising this compound is intended for the preparation of a drug aimed at treating and preventing diabetes or improving diabetic complications. He has 1 patent to his name.
Career Highlights
Zhuangrong Sun is affiliated with the Institute of Radiation Medicine, Academy of Military Medical Sciences, PLA. His work at this esteemed institution has allowed him to focus on innovative research that has the potential to impact public health significantly.
Collaborations
He has collaborated with notable colleagues, including Zhiyun Kang and Zuze Wu, who share his commitment to advancing medical science and improving treatment options for diabetes.
Conclusion
Zhuangrong Sun's contributions to diabetes treatment through his innovative patent highlight his role as a key figure in pharmaceutical research. His work continues to inspire advancements in medical science and offers hope for improved health outcomes for individuals affected by diabetes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile